| 【公司研究】巨子生物 (2367 HK) - 双十一收官，双品牌强势增长 |
| 【行业研究】互联网 - 双十一趋势观察：GMV增速好于预期 |
| 【Company Research】TME (TME US) - Inline 3Q24 results; SVIP evolves as the new growth driver |
| 【Company Research】FIT Hon Teng (6088 HK) - 3Q24 first take: Earnings in-line with solid margin recovery; Focus on GB200 products in 4Q24E |
| 【公司研究】联影医疗 (688271 CH) - 投资者日要点：国之重器，扬帆出海 |
| 【Company Research】Leapmotor (9863 HK) - Clear brand positioning with unique overseas model; initiate with BUY |
| 【Company Research】Carote Ltd (2549 HK) - Global quality & affordable kitchenware brand; initiate at BUY |
| 【公司研究】博瑞医药 (688166 CH) - 双靶点GLP1/GIP 创新药未来可期；首予买入 |
| 【Company Research】Xiaomi (1810 HK) - 3Q24E preview: Continued strength in core business and EV upside; Raise TP to HK$32.29 |
| 【Company Research】China Life (2628 HK) - 3Q NPAT boosted by net fair value gains; expect resilient full-year NBV upswing |
公司地址：香港中環花園道三號冠君大廈45-46樓
電話：（852） 3900-0888 傳真：（852） 3761-8788
招銀國際版權所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
